Differences between clinical trials and postmarketing use

2003152 citationsJournal Articlebronze Open Access

Authors

Karin Martin · Galen University

Bernard Bégaud · Galen University

Philippe Latry · Polyclinique Bordeaux Nord Aquitaine

Ghada Miremont‐Salamé · Galen University

A Fourrier · Galen University

Nicholas Moore · Galen University

Abstract

These results plead for systematic ad hoc observational postmarketing studies for any novel and/or expensive medicine to assess the relevance of premarketing data.

Topics & Keywords

Statistical Methods in Clinical Trials Health Systems, Economic Evaluations, Quality of Life Pharmaceutical Economics and Policy

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: British Journal of Clinical Pharmacology

Volume 57, Issue 1, pp. 86-92

DOI: 10.1046/j.1365-2125.2003.01953.x

Field-Weighted Citation Impact: 5.33